研究成果


第 1 到 144 筆結果，共 144 筆。

公開日期標題作者來源出版物scopusWOS全文
12024miR-622 Increases miR-30a Expression through Inhibition of Hypoxia-Inducible Factor 1α to Improve Metastasis and Chemoresistance in Human Invasive Breast Cancer CellsCheng, Chun-Wen; Liu, Yu-Fan; Liao, Wen-Ling; Chen, Po-Ming; Hung, Yueh-Tzu; Lee, Huei-Jane; Cheng, Yu-Chun; Wu, Pei-Ei; YEN-SHEN LU ; Shen, Chen-YangCancers
22024A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimensLee, Yi-Hsuan; Huang, Chung-Yen; Hsieh, Yu-Han; Yang, Chia-Hung; Hung, Yu-Ling; Chen, Yung-An; Lin, Yu-Chieh; Lin, Ching-Hung; JIH-HSIANG LEE ; Wang, Ming-Yang; Kuo, Wen-Hung; Lin, Yen-Yin; YEN-SHEN LU BMC cancer
32024Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancerChou, Wen-Cheng; Chen, Wei-Ting; Kuo, Chun-Tse; Chang, Yao-Ming; YEN-SHEN LU ; Li, Chia-Wei; Hung, Mien-Chie; Shen, Chen-YangCell reports
42024Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical TrialWEI-WU CHEN ; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; YA-FANG CHEN ; DWANG-YING CHANG ; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; ANN-LII CHENG ; YEN-SHEN LU JAMA oncology0
52023Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysisPeng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU Cancer medicine00
62023Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in TaiwanHuang, Meng-Chuan; Huang, Tz-Ting; Feng, Hsin-Chun; I-CHUN CHEN ; Chang, Chiao-I; Wang, Tsu-Nai; WEN-HUNG KUO ; Wang, Ming-Yang; LI-WEI TSAI ; Li, Szu-Yi; Huang, Chiun-Sheng; YEN-SHEN LU ; CHING-HUNG LIN Nutrients0
72023Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trialsAndré, F; Su, F; Solovieff, N; Hortobagyi, G; Chia, S; Neven, P; Bardia, A; Tripathy, D; YEN-SHEN LU ; Lteif, A; Taran, T; Babbar, N; Slamon, D; Arteaga, C LAnnals of oncology : official journal of the European Society for Medical Oncology20
82023The Application of18F-FES PET in Clinical Cancer Care: A Systematic ReviewHuang, Ya-Ting; WEI-WU CHEN ; Chen, Li-Yu; Huang, Ya-Yao; YEN-SHEN LU Clinical nuclear medicine00
92023Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancerWEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU Breast cancer research and treatment00
102023Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian WomenCHING-HUNG LIN ; Zahid, Muhammad; WEN-HUNG KUO ; Hu, Fu-Chang; MING-YANG WANG ; I-CHUN CHEN ; Beseler, Cheryl L; Mondal, Bodhisattwa; YEN-SHEN LU ; Rogan, Eleanor G; ANN-LII CHENG Cancer prevention research (Philadelphia, Pa.)00
112023Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinomaZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG Cancer letters11
122023Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinomaHUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN Breast cancer research : BCR00
132023Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity studyDai, Ming-Shen; Chao, Ta-Chung; Chiu, Chang-Fang; YEN-SHEN LU ; Shiah, Her-Shyong; Jackson, Christopher G C A; Hung, Noelyn; Zhi, Jianguo; Cutler, David L; Kwan, Rudolf; Kramer, Douglas; Chan, Wing-Kai; Qin, Albert; Tseng, Kuan-Chiao; Hung, Cheung Tak; Chao, Tsu-YiTherapeutic advances in medical oncology00
142022Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident VaricesWEI-LI MA ; DWANG-YING CHANG ; CHING-HUNG LIN ; KAO-LANG LIU ; PO-CHIN LIANG ; HUANG-CHUN LIEN ; Hu, Chan-Chuan; Huang, Ling-Yun; Yeh, Yi-Chun; YEN-SHEN LU The oncologist01
152022Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patientsPO-HAN LIN ; Chen, Shin-Cheh; Tseng, Ling-Ming; KING-JEN CHANG ; Huang, Ai-Chu; Cheng, Kuo-Chih; Yang, Karen; Wu, Hui-Chen; Chao, Tsu-Yi; Chang, Yuan-Ching; Lin, Peng-Chan; WEN-HUNG KUO ; Kuo, Wen-Lin; CHING-HUNG LIN ; Chen, Huo-Mu; Yeh, Dah-Cherng; Liu, Liang-Chih; Liu, Chun-Yu; MING-YANG WANG ; Chiao Lo ; YEN-SHEN LU ; CHIUN-SHENG HUANG Breast cancer research and treatment54
162022Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical TrialYEN-SHEN LU ; Im S.-A.; Colleoni M.; Franke F.; Bardia A.; Cardoso F.; Harbeck N.; Hurvitz S.; Chow L.; Sohn J.; Lee K.S.; Campos-Gomez S.; Vazquez R.V.; Jung K.H.; Babu K.G.; Wheatley-Price P.; De Laurentiis M.; Im Y.-H.; Kuemmel S.; El-Saghir N.; O'Regan R.; Gasch C.; Solovieff N.; Wang C.; Wang Y.; Chakravartty A.; Ji Y.; Tripathy D.Clinical Cancer Research7538
172022HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysisTan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN ; YEN-SHEN LU ; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S.BMC Medicine5341
182022A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast CancerKuemmel S.; Campone M.; Loirat D.; Lopez R.L.; Thaddeus Beck J.; de Laurentiis M.; Im S.-A.; Kim S.-B.; Kwong A.; Steger G.G.; Adelantado E.Z.; Duhoux F.P.; Greil R.; Kuter I.; YEN-SHEN LU ; Tibau A.; ?zg?ro?lu M.; Scholz C.W.; Singer C.F.; Vega E.; Wimberger P.; Zamagni C.; Couillebault X.-M.; Fan L.; Guerreiro N.; Mataraza J.; Sand-Dejmek J.; Chan A.Clinical Cancer Research1515
192021Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patientsI-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU Breast (Edinburgh, Scotland)22
202021High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East AsiaLIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG NPJ breast cancer44
212021Phase ib study of ribociclib plus fulvestrant and ribociclib plus fulvestrant plus pi3k inhibitor (alpelisib or buparlisib) for HR? advanced breast cancerTolaney S.M.; Im Y.-H.; Calvo E.; YEN-SHEN LU ; Hamilton E.; Forero-Torres A.; Bachelot T.; Maur M.; Fasolo A.; Tiedt R.; Nardi L.; Stammberger U.; Abdelhady A.M.; Ruan S.; Lee S.C.Clinical Cancer Research1410
222021Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectivesDWANG-YING CHANG ; WEI-LI MA ; YEN-SHEN LU Therapeutics and Clinical Risk Management2824
232021Matching-adjusted indirect comparison of ribociclib plus fulvestrant versus palbociclib plus letrozole as first-line treatment of hr+/her2? advanced breast cancerFasching P.A.; Delea T.E.; YEN-SHEN LU ; De Boer R.; Hurvitz S.A.; Moynahan A.; Chandiwana D.; Lanoue B.; Hu H.; Thuerigen A.; O��shaughnessy J.Cancer Management and Research10
242021Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal WomenYEN-SHEN LU ; Wong A.; Kim H.-J.Frontiers in Oncology98
252021Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and RibociclibBardia A.; Su F.; Solovieff N.; Im S.-A.; Sohn J.; Lee K.S.; Campos-Gomez S.; Jung K.H.; Colleoni M.; V?zquez R.V.; Franke F.; Hurvitz S.; Harbeck N.; Chow L.; Taran T.; Lorenc K.R.; Babbar N.; Tripathy D.; YEN-SHEN LU JCO Precision Oncology
262021Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensDai M.S.; Feng Y.H.; Chen S.W.; Masuda N.; Yau T.; Chen S.T.; YEN-SHEN LU ; Yap Y.S.; Ang P.C.S.; Chu S.C.; Kwong A.; Lee K.S.; Ow S.; Kim S.B.; Lin J.; Chung H.C.; Ngan R.; Kok V.C.; Rau K.M.; Sangai T.; Ng T.Y.; Tseng L.M.; Bryce R.; Bebchuk J.; Chen M.C.; Hou M.F.Breast Cancer Research and Treatment1010
272021Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic componentsHUANG-CHUN LIEN ; Lee Y.-H.; I-CHUN CHEN ; CHING-HUNG LIN ; WEI-WU CHEN ; Lu Y.-T.; YEN-SHEN LU Virchows Archiv1513
282021Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsHata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU ; Yap Y.-S.; Tamura K.; Fujiwara Y.Clinical and Translational Science21
292021A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancerYEN-SHEN LU ; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H.Clinical Cancer Research2316
302021Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1André F.; Ciruelos E.M.; Juric D.; Loibl S.; Campone M.; Mayer I.A.; Rubovszky G.; Yamashita T.; Kaufman B.; YEN-SHEN LU ; Inoue K.; Pápai Z.; Takahashi M.; Ghaznawi F.; Mills D.; Kaper M.; Miller M.; Conte P.F.; Iwata H.; Rugo H.S.Annals of Oncology275
312021A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancerSchmid P.; Sablin M.-P.; Bergh J.; Im S.-A.; YEN-SHEN LU ; Mart?nez N.; Neven P.; Lee K.S.; Morales S.; P?rez-Fidalgo J.A.; Adamson D.; Gon?alves A.; Prat A.; Jerusalem G.; Schlieker L.; Espadero R.-M.; Bogenrieder T.; Huang D.C.-L.; Crown J.; Cort?s J.Breast Cancer Research1715
322021An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast CancerYEN-SHEN LU ; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R.Targeted Oncology55
332020Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)Harbeck N.; Franke F.; Villanueva-Vazquez R.; YEN-SHEN LU ; Tripathy D.; Chow L.; Babu G.K.; Im Y.-H.; Chandiwana D.; Gaur A.; Lanoue B.; Rodriguez-Lorenc K.; Bardia A.Therapeutic Advances in Medical Oncology3631
342020Response to Sung, Rosenberg, and YangCHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Yeo W.; Ueno T.; Li H.; Huang S.-M.; YEN-SHEN LU Journal of the National Cancer Institute00
352020Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese WomenChuang S.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; Hsiung C.A.Oncologist34
362020Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survivalWEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU Journal of Neuro-Oncology1713
372020Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models (Scientific Reports, (2019), 9, 1, (10898), 10.1038/s41598-019-45319-4)Kuo, C.-T.; Chen, C.-L.; Li, C.-C.; Huang, G.-S.; Ma, W.-Y.; Hsu, W.-F.; CHING-HUNG LIN ; YEN-SHEN LU ; ANDREW WO Scientific Reports00
382020Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOSPark Y.H; Senkus-Konefka E; Im S.-A; Pentheroudakis G; Saji S; Gupta S; Iwata H; Mastura M.Y; Dent R; YEN-SHEN LU ; Yin Y; Smruti B.K; Toyama T; Malwinder S; Lee S.C; Tseng L.-M; Kim J.H; Kim T.-Y; Suh K.J; Cardoso F; Yoshino T; Douillard J.-Y.Annals of Oncology3229
392020A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese womenLien, Guang-Wen; WU-SHIUN HSIEH ; WEN-HUNG KUO ; CHING-HUA KUO ; Huang, Ching-Chun; YUE-LIANG GUO; DWANG-YING CHANG ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN ; PAU-CHUNG CHEN Environment International4835
402020Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ? 2 HER2-directed regimens: Phase III NALA trialSaura C.; Oliveira M.; Feng Y.-H.; Dai M.-S.; Chen S.-W.; Hurvitz S.A.; Kim S.-B.; Moy B.; Delaloge S.; Gradishar W.; Masuda N.; Palacova M.; Trudeau M.E.; Mattson J.; Yap Y.S.; Hou M.-F.; De Laurentiis M.; Yeh Y.-M.; Chang H.-T.; Yau T.; Wildiers H.; Haley B.; Fagnani D.; YEN-SHEN LU ; Crown J.; Lin J.; Takahashi M.; Takano T.; Yamaguchi M.; Fujii T.; Yao B.; Bebchuk J.; Keyvanjah K.; Bryce R.; Brufsky A.; NALA InvestigatorsJournal of Clinical Oncology360311
412020Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western PopulationsChen C.-H.; YEN-SHEN LU ; ANN-LII CHENG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; Wang M.-Y.; Chao M.; I-CHUN CHEN ; Kuo C.-W.; TZU-PIN LU ; CHING-HUNG LIN Oncologist3232
422019Overall survival with ribociclib plus endocrine therapy in breast cancerIm S.-A; YEN-SHEN LU ; Bardia A; Harbeck N; Colleoni M; Franke F; Chow L; Sohn J; Lee K.-S; Campos-Gomez S; Villanueva-Vazquez R; Jung K.-H; Chakravartty A; Hughes G; Gounaris I; Rodriguez-Lorenc K; Taran T; Hurvitz S; Tripathy D.New England Journal of Medicine607556
432019Ribociclib and Endocrine Therapy in Breast Cancer. ReplyIm S.-A; YEN-SHEN LU ; Tripathy D.The New England journal of medicine22
442019Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US PopulationCHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative GroupJournal of the National Cancer Institute8173
452019Insights into Breast Cancer in the East vs the West: A ReviewYap Y.-S.; YEN-SHEN LU ; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN ; Toi M.; Wu J.; Lee S.-C.JAMA Oncology8466
462019Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancerIwata H; Masuda N; Kim S.-B; Inoue K; Rai Y; Fujita T; Chiu J; Ohtani S; Takahashi M; Miyaki T; YEN-SHEN LU ; Xu B; Yap Y.S; Bustam A; Yao B; Zhang B; Bryce R; Chan A.Future Oncology97
472019Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppressionYeo W.; Ueno T.; CHING-HUNG LIN ; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; YEN-SHEN LU ; The Asian Breast Cancer Cooperative GroupBreast Cancer Research and Treatment2927
482019PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 studyMING-HAN YANG ; I-CHUN CHEN ; YEN-SHEN LU Journal of the Formosan Medical Association2117
492019Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer modelsKuo C.-T.; Chen C.-L.; Li C.-C.; Huang G.-S.; Ma W.-Y.; Hsu W.-F.; CHING-HUNG LIN ; YEN-SHEN LU ; ANDREW WO Scientific Reports65
502019Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancerAndr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU ; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.New England Journal of Medicine14401286
512018Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MSChiu, Huai Hsuan; Liao, Hsiao Wei; YU-YUN SHAO ; YEN-SHEN LU ; CHING-HUNG LIN ; Tsai, I. Lin; CHING-HUA KUO Analytica Chimica Acta4945
522018Association of pregnancy and mortality in women diagnosed with breast cancer: A Nationwide Population Based Study in TaiwanChuang S.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; Hsiung C.A.International Journal of Cancer109
532018Adiposity, inflammation, and breast cancer pathogenesis in Asian WomenIyengar N.M.; I-CHUN CHEN ; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; YEN-SHEN LU ; Hsueh T.-H.; ANN-LII CHENG ; Hudis C.A.; CHING-HUNG LIN ; Dannenberg A.J.Cancer Prevention Research3230
542018Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancerBANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH European Radiology99
552018Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trialTripathy D; Im S.-A; Colleoni M; Franke F; Bardia A; Harbeck N; Hurvitz S.A; Chow L; Sohn J; Lee K.S; Campos-Gomez S; Villanueva Vazquez R; Jung K.H; Babu K.G; Wheatley-Price P; De Laurentiis M; Im Y.-H; Kuemmel S; El-Saghir N; Liu M.-C; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; YEN-SHEN LU The Lancet Oncology633545
562018A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerWEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer ConsortiumJapanese Journal of Clinical Oncology43
572018Effect of glucocorticoid use on survival in patients with stage I–III breast cancerCHING-HUNG LIN ; Chuang P.-Y.; You S.-L.; CHUN-JU CHIANG ; CHIUN-SHENG HUANG ; Wang M.-Y.; Chao M.; YEN-SHEN LU ; ANN-LII CHENG ; Tang C.-H.Breast Cancer Research and Treatment88
582017Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialMartin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; KING-JEN CHANG ; Arance A.M; Efrat N; Sarosiek T; Grzeda L; Manalo Y; Smith J.C; Vaziri I; Healey T; Rahim Y; Toma?evi? Z; Luk C; Dingle B; Franco S; Sorensen P.G; Anand A; Khan S; Fountzilas G; Aogi K; Shimizu S; Mikulova M; Denduluri N; Spanik S; Somer R.A; Flynn P.J; Coward J; Mainwaring P; Jerusalem G; Segura-Ojezzar C; Levy C; Delozier T; Khayat D; ?eparovi? R; Coleman R.E; Rolles M.J; Maisano R; Nardi M; Ito Y; Yumuk P.F; Basaran G; Serdar Turhal N; Wilkinson M.J; Green N.B; Gokmen E; Sidrys A.P; Hallmeyer S; Testori D.J; Sridhar S; Chang J; Sun Q; Jara-Sanchez C; Rubio X; Garrido M.L; De La Haba Rodriguez J.R; Bashford A; Perello Martorell A; Avelia Mestre A; Rifa Ferrer J; del Barco Berron S; Nagy Z; Tanaka M; Im Y.-H; Carroll R.R; Dickerson L.C; Mace J.R; Ruiz Borrego M; Rivera R; Klein L.M; Ruxer R; Wilks S.T; Kotasek D; Popov V; Taskova V; Marinova-Venkova V; Timcheva C; Desbiens C; Kim S.-B; Ayoub J.-P; Grenier D; Marschner N; Tesch H; Lueck H.-J; Janssen J; Schwaner I; Wahlstrom S; Brix E.H; Vallentin S; Jakobsen E.H; Kristensen D; Andreeva A; Glavicic V; Calvo Plaza I; Anton Torres A; Veyret C; Bergerat J.-P; Bourbouloux E; Ella W.A; Algurafi H; Ciceniene A; Robinson A; Kim S.J; Taguchi T; Juozaityte E; Madretsma S; Radema S; Czerniawska-Meier M; Rogowski W; Wagnerova M; Richards D.A; Inoue K; Tan-Chiu E; Vasileios A; Henderson C.A; Holden V.R; Wang X; Tong Z; Yang J; Gonzalez M.E; Rezai M; Hackmann J; Overkamp F; de Due?as E.M; de las Heras B.B; Dourthe L.M; Chocteau-Bouju D; Bougnoux P; Kakolyris S; Kalofonos H; Pectasidis D; Ng T.Y; Pajkos G; Heijns J.B; Somogyine E.E; Tonini G; Giuffrida D; Takao S; Ishitobi M; Inaji H; Tokuda Y; Wozniak K; Lungulescu D; YEN-SHEN LU ; Armstrong A.C; Chang K.-J; Hill J; Croot C.C; Dekker A; Belman N.D; Conde M; Michaelson R.A; Kemmer K; Chui S; Luoh S.-W; Link J.S; Nahum K; Greenspan A.R; Nichols J.C; Encarnacion C.A; Niederman T.M.J; Lee T; Alexander R; Gordon R; Tomova A; Rauch D; Joy A.A; Popescu R.A; Rojas G.A; Vanasek J; Neunhoeffer T; Barinoff J; Graffunder G; Wolfgang A; Bojko P; Heinrich B; von der Assen A; Bryce R; Antonovic B.J; Adrian L; Ramos Vazquez M; Gonzalez Santiago S; Dieras V; Bishop J.M; Perren T.J; Varthalitis I; Mavroudis D; Georgoulias V; Wong A; Chow L.W.C; Yau C.C.T; Liang R.H.-S; Pik? B; W?ber A; Kaufman B; Drumea K; Nuzzo F; De Matteis A; Nuzzo F; Moran S; Carteni G; Tokunaga E; Ishida M; Ohno S; Sato N; Kuroi K; Nishimura R; Watanabe J; Choi Y.J; Park K.H; Yao B; Wojtukiewicz M; Jassem J; Loman N; Askoy S; Altundag M.K; Saip P; Ali M.A; Wade J.L; III, Chien A.J; Brandt D; Xu F; Novik Y; Jani C; Rice R.L; Gaffar Y.A.R; Keaton M.R; Bajaj R; Kimmick G; Campbell D; De Boer R.H; Turnquest T; Auerbach A; Lucas S; Dube P; Xu B; Schilling J; Apel K; Sorensen P.G; Vestlev P.M; Jensen B.B; Haahr V; Lescure A.R; Buyse M; Grana Suarez B; Saura Manich C; Jacquin J.-P; Samreen A; Boiangiu I; Dank M; Falci C; Jirillo A; Cinieri S; Ueno T; Chan A; Sato F; Yamashiro H; Sugie T; Lee K.S; Ro J.S; Park I.H; Bustam A.Z; Suszko-Kazarnowicz M; Piktel A; Krzemieniecki K; Harvey V; Iorga P.G; Yap Y.S; Kakalejcik M; Sevinc A; Ozguroglu M; Chen S.-C; Greenberg R.H; Eisemann A.D; Droder R; Abbasi M.R; Tomek R; Vaysburd M; Caldera H.J; Haley B.B; Robin E; Inhorn R.C; Hufnagel D; Kenyon P.D; Spremulli E; Silverman P; Jain S; Robert N.J; Weigand R; Mebis J; Koynova T; Lesperance B; Prausova J; Kohne C.-H; Schneeweiss A; Jackisch C; Fuxius S; Cubedo Cervera R; Gore I; Urruticoechea Ribate A; Pernas Simon S; Valero Gallego J; Arcusa Lanza A; del Pilar Alvarez M; Florian Gerico J; Cany L; Stebbing J; Labudovic D; Gugic D; Jr; Vrbanec D; Roila F; Barni S; Bidoli P; Mukai H; Bermudez V; Eniu A; Mirtsching B.C; Ibrahim E; Trey J; Smith J.W; Hergenroeder P.F; Mahmood A; Gonzalez A; Kaplan E.H; Ban S; Patel D; Clowney B; Hoelzer K; Schwartz G.H; Salkeni M; II, Masuda N; Abraham J; Narula S; Jabboury K; Mocharnuk R.S; McDonough R.H; Sikes D.H; Kawanchi R.H; Schlabach L; McCachren S.S; Jr; Di Sean Kendall S; Cosgriff T.M; Dreisbach L; DeMichele A; Pawl L; Lucas J; Shinn L.C; Alkhouri N; Monga M; Lindquist D.L; Anderson T.C; Harker W.G; Khurshid H; Witherby S; Erickson N; Traynor A; Bose R; Pluard T.J; Jones M.C; Prakash S; Volterra F; Capo G; Petrakova K; Flaherty L.E; Gartner E; Baidas S; Okazaki I; Nguyen B; Rakowski T; Oliff I; Leach J.W; Anderson D; Kubiak K; Guerrero Zotano A; Tsai M; Vroman P; Deleu I; Lybaert W; Borms M; Couture F; Wilson J.J; Hunt G; Holland D.R; Mingrone W; Simon A.R; Wang S; Liu D; Jiang Z; Benesova V; Smakal M; Garnolova P; Vesper A.-S; Neumann M; Janni W; Liedtke C; Konstantinovic Z.N; Fischer D; Grischke E.-M; Seeger D; Moebus V; Prechtl A; Carlos Camara Toral J; Sanchez Munoz A; Gonzalez Jimenez S; Cassinello Espinosa J; Cirauqui B; Iannotti N.O; Margeli Vila M; Batista Lopez N; Chacon Lopez-Muniz J.I; de la Cruz Mora M.A; Mailliez A; Vanlemmens L; Pouessel D; Espie M; Conibear J; Roylance R; Tassone P; Harnett A; Geffen D; Ruggeri E.M; Gamucci T; Van Groeningen C.J; Banas R; Alkis N; Hou M.-F; Krie A.K; Vrindavanam N.S; Rodriguez G.I; Howard O.M; Citrin D; Morginstin M.S; Desai A; Sanchez I.J; Nixon D.A; Jr; Beatty P.G; Edmiston K; McLaughlin M; J??ez Martinez N; Eneman J.D; Lynch C.A; O'Brien E; Call J.A; Lanier K.S; Conlin A; Brooks D.J; McIntyre K; Saltzman M.A; Castine M.J; Crespo Massieu C; III, Ortega G.L; Choi Y.M; Reynolds C.H; Brescia F.A; Kramer R; Kohn A.D; Micha J.P; Rhee J.M; Shah S; Riseberg D.A; Smickoska S; Patterson W.K; Salmon J.-P; Andre C; Bols A; D'hondt R; Luce S; Nouwynck C; Pelgrims G; Richard V; Verschuere J; Somali I; Geldhof K; Caspar C; Luo R; Bednarik O; Schwedler K; Schmidt M; Neumeister R; Bischoff J; Rack B; Repp R; Yilmaz U; Fries S; Adrion R; Schulz V; Klare P; Danei M; Ossenbuhl D; Kusche J.M; Griesinger F; Baena Canada J.M; Martinez del Prado P; Alonso M.G; Machover D; Mayeur D; Trufflandier N; Delecroix V; Mousseau M; Mouret-Reynier M.-A; Nabholtz J.-M; Chetiyawardana A.D; Papandreou C; Hornyak L; Rosales A.M; Faluhelyi Z; Simo E; Di Palma M; Cognetti F; Gorzegno G; Dogliotti L; Gridelli C; Falcone A; Soto Parra H; Buscarino C; Cold S; Im S.-A; Sanchez Llamas B; Dercksen W; Erdkamp F; Ruit J.B; Braun H; Portielje J.E.A; Ciltas A; Buyukberber S; Benekli M; Knoop A.S; Zahalsky A.J; Jaslow R; Thomas G.W; Maini A; Wiznitzer I; Khojasteh A; Francisco Gonzalez M; Kong L.R; Padmanabhan A; Conkright W.A; Patt D; Swain S.M; Faig D.E; Jain K; Yanagihara R.H; Ottaviano Y; Delmas A; Steele H.A; Rainey G.K; Harris P.J; Burris J.K; Hellerstedt B.A; Rupard E.J; Tan E; Whitworth P.W; Bova A.R; Anderson I.C; Shirinian M; Tin-u C; O'Rourke T.J; Roberts M.S; Francisco M; Morales Murillo S; Pierson A.S; Byeff P.D; Kovach P.A; Caton J.R; Rarick M.U; Schimidt W.G; Stopeck A.T; Swart R; Mayer I.A; Carrillo Flores M.R; Alemany C.A; Lozada B; Weinstein P.L; Wang W; Porubcin M; Ellison D.M; Geils G.F; Rivera E; Charif M; Means-Powell J.A; ExteNET Study Group; Hui R; Senecal F.M; De Boer R.H; Shen Z; Luczak A.A; Chui J.W.Y; Tsang J.W.-H; Lang I; Rai Y; Hozumi Y; Ten Tije A.J; Bhandari M; Osborne C.R.C; Ohtani S; Higaki K; Watanabe K; Taguchi K; Takahashi M; Filipovic S; Hansen V.L; Rao V.P; Gupta M; Petrov P; Coudert B; Vojnovic Z; Polya Z; Miyaki T; Yamamoto N; Brincat S; Lesniewski-Kmak K; Chmielowska E; Birhiray R.E; Citron M.L; Papish S.W; Berry W.R; Langkjer S.TThe Lancet Oncology445387
592017Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasmaChiu H.-H.; Tsai I.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO Analytical and Bioanalytical Chemistry2015
602017Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patientsChow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S.; Patel J.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; Zhu L.; Chow C.Y.C.; Loo W.T.Y.; Gl?ck S.; Toi M.Asia-Pacific Journal of Clinical Oncology1617
612017Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to TamoxifenI-CHUN CHEN ; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; CHING-HUNG LIN ; Wei-Wu Chen T.; ANN-LII CHENG ; YEN-SHEN LU Scientific Reports2320
622016Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerPO-HAN LIN ; WEN-HUNG KUO ; Huang A.-C.; YEN-SHEN LU ; CHING-HUNG LIN ; SUNG-HSIN KUO ; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; SUNG-LIANG YU ; KING-JEN CHANG ; PEI-LUNG CHEN ; YEN-HSUAN NI ; CHIUN-SHENG HUANG Oncotarget7464
632016Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancerLove R.R.; Hossain S.M.; Hussain Md.M.; Mostafa M.G.; Laudico A.V.; Siguan S.S.S.; Adebamowo C.; Sun J.-Z.; Fei F.; Shao Z.-M.; Liu Y.; Akram Hussain S.Md.; Zhang B.; Cheng L.; Panigaro S.; Walta F.; Chuan J.H.; Mirasol-Lumague M.R.; Yip C.-H.; Navarro N.S.; Jr.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; Ferdousy T.; Salim R.; Akhter C.; Nahar S.; Uy G.; Young G.S.; Hade E.M.; Jarjoura D.European Journal of Cancer65
642016A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancerBANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH BMC Cancer2017
652016Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG Scientific Reports1817
662016Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patientsWEI-WU CHEN ; CHING-HUNG LIN ; YEN-SHEN LU Translational Cancer Research00
672016Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosisI-CHUN CHEN ; CHING-HUNG LIN ; I-SHIOW JAN ; ANN-LII CHENG ; YEN-SHEN LU Journal of the Formosan Medical Association1811
682016Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without RadiotherapySHIH-FAN LAI ; YU-HSUAN CHEN ; WEN-HUNG KUO ; HUANG-CHUN LIEN ; Wang M.-Y.; YEN-SHEN LU ; Chiao Lo ; SUNG-HSIN KUO ; ANN-LII CHENG ; CHIUN-SHENG HUANG Annals of Surgical Oncology3128
692015Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficientWu L.-A.; Chang R.-F.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; Chen H.-H.; JO-YU CHEN ; YEUN-CHUNG CHANG Journal of Magnetic Resonance Imaging1719
702015Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyYEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer ConsortiumClinical Cancer Research6559
712015TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysCHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG Scientific Reports1011
722015A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosisWu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU BMC Cancer4836
732015High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian countryCHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG PLoS ONE106
742015Associations between medical conditions and breast cancer risk in asians: A nationwide population-based study in TaiwanChuang S.-C.; Wu G.-J.; YEN-SHEN LU ; CHING-HUNG LIN ; Hsiung C.A.PLoS ONE2827
752014Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based studyCHING-HUNG LIN ; Chuang P.-Y.; CHUN-JU CHIANG ; YEN-SHEN LU ; ANN-LII CHENG ; WEN-HUNG KUO ; CHIUN-SHENG HUANG ; Lai M.-S.; You S.-L.; Tang C.-H.Oncologist3939
762014No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifenWEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU Breast Cancer Research and Treatment108
772014A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesCHIA-CHI LIN ; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU ; Su W.-P.; KUN-HUEI YEH ; YEN-SHEN LU ; ANN-LII CHENG ; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; CHIH-HSIN YANG British Journal of Cancer6264
782014Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significanceHUANG-CHUN LIEN ; Lee Y.-H.; YUNG-MING JENG ; CHING-HUNG LIN ; YEN-SHEN LU ; Yao Y.-T.Histopathology3328
792014Quantification of target analytes in various biofluids using a postcolumn infused-internal standard method combined with matrix normalization factors in liquid chromatography-electrospray ionization mass spectrometryLiao H.-W.; Tsai I.-L.; GUAN-YUAN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO Journal of Chromatography A1212
802013Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patientsDewi S; Larsen S; Srimuninnimit V; YEN-SHEN LU ; Manuaba T; Lindk?r-Jensen S.Open Breast Cancer Journal70
812013Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significanceHUANG-CHUN LIEN ; Wang C.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Hsiao L.-P.; Yao Y.-T.Human Pathology1212
822013CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancerSUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG BioMed Research International99
832013The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclinesWEI-WU CHEN ; DWANG-YING CHANG ; Huang S.-M.; CHING-HUNG LIN ; CHIUN HSU ; Lin M.-H.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; ANN-LII CHENG Breast45
842013Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasWu P.-F.; Huang W.-C.; CHIH-HSIN YANG ; YEN-SHEN LU ; JIN-YUAN SHIH ; SHANG-GIN WU ; CHING-HUNG LIN ; ANN-LII CHENG Journal of Neuro-Oncology85
852013Distant metastasis in triple-negative breast cancerTseng L.M.; Hsu N.C.; Chen S.C.; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; Li H.; Lin Y.C.; Chang H.K.; Chao T.C.; Ouyang F.; Hou M.F.Neoplasma9485
862013Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisationCHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG Journal of Clinical Pathology1314
872012Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWEN-HUNG KUO ; PO-HAN LIN ; Huang A.-C.; YIN-HSIU CHIEN ; Liu T.-P.; YEN-SHEN LU ; Bai L.-Y.; Sargeant A.M.; CHING-HUNG LIN ; ANN-LII CHENG ; FON-JOU HSIEH ; WUH-LIANG HWU ; KING-JEN CHANG Journal of Human Genetics1919
882012Hashimoto's encephalopathy as the cause of deteriorating consciousness during treatment of leptomeningeal carcinomatosis from breast cancerYI-HSIN LIANG ; Wu P.-F.; CHING-HUNG LIN ; YEN-SHEN LU Journal of Clinical Oncology00
892012Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transitionWang C.-C.; JAU-YU LIAU ; YEN-SHEN LU ; Chen J.-W.; Yao Y.-T.; HUANG-CHUN LIEN Histopathology4036
902012The emerging epidemic of estrogen-related cancers in young women in a developing Asian countryCHING-HUNG LIN ; Chen Y.-C.; CHUN-JU CHIANG ; YEN-SHEN LU ; KUAN-TING KUO ; CHIUN-SHENG HUANG ; WEN-FANG CHENG ; Lai M.-S.; You S.-L.; ANN-LII CHENG International Journal of Cancer4645
912012Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYU-YUN SHAO ; ZHONG-ZHE LIN ; CHIUN HSU ; Lee, Kuan-Der; Hsiao, Chi-Huang; YEN-SHEN LU ; Huang, Chien-Chung; YING-CHUN SHEN ; CHIH-HUNG HSU ; ANN-LII CHENG Oncology2625
922012Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapyKuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG BMC Cancer1916
932012The impact of diabetes mellitus on prognosis of early breast cancer in AsiaWEI-WU CHEN ; YU-YUN SHAO ; Shau W.-Y.; ZHONG-ZHE LIN ; YEN-SHEN LU ; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG ; Lai M.-S.Oncologist3634
942012Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinomaYEN-SHEN LU ; Chou C.-H.; KAI-YUAN TZEN ; Gao M.; ANN-LII CHENG ; Kulp S.K.; CHIA-HSIEN CHENG International Journal of Radiation Oncology Biology Physics2120
952011Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2]I-CHUN CHEN ; CHING-HUNG LIN ; YEN-SHEN LU JAMA - Journal of the American Medical Association94
962011IκB kinases increase Myc protein stability and enhance progression of breast cancer cellsYeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG Molecular Cancer2423
972011Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001SUNG-HSIN KUO ; CHIH-HUNG HSU ; Chen L.-T.; YEN-SHEN LU ; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; KUN-HUEI YEH ; ANN-LII CHENG European Journal of Cancer1717
982011Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; KUAN-TING KUO ; Wang C.-C.; You S.-L.; PO-HAN LIN ; DWANG-YING CHANG ; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG Journal of Clinical Pathology88
992011Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancerYEN-SHEN LU ; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO ; CHIUN-SHENG HUANG Cancer Chemotherapy and Pharmacology108
1002011Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern eraI-CHUN CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; HUANG-CHUN LIEN ; CHIUN HSU ; WEN-HUNG KUO ; YEN-SHEN LU ; ANN-LII CHENG Breast Cancer Research and Treatment8474
1012011Cisplatin as an active treatment in zoledronate-refractory hypercalcemiaPO-HAN LIN ; Chiu C.-F.; YEN-SHEN LU Annals of Oncology11
1022011The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast CancerJANE WANG ; TIFFANY TING-FANG SHIH ; RUOH-FANG YEN ; YEN-SHEN LU ; Chen C.-Y.; TSUI-LIEN MAO ; CHING-HUNG LIN ; WEN-HUNG KUO ; Tsai Y.-S.; KING-JEN CHANG ; KUO-LIONG CHIEN Academic Radiology107
1032010Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphomaChiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG Cancer Letters1919
1042010Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyCHING-HUNG LIN ; HUANG-CHUN LIEN ; Hu F.-C.; YEN-SHEN LU ; SUNG-HSIN KUO ; Wu L.-C.; You S.-L.; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG Journal of Zhejiang University: Science B811
1052010Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an exampleCHIUN-SHENG HUANG ; CHING-HUNG LIN ; YEN-SHEN LU ; Shen C.-Y.Journal of Steroid Biochemistry and Molecular Biology4244
1062010Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulationPO-HAN LIN ; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; KUN-HUEI YEH Anticancer Research64
1072010O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersPEI-FANG WU; KUAN-TING KUO ; LU-TING KUO ; YI-TING LIN; WEI-CHUNG LEE; YEN-SHEN LU ; CHIH-HSIN YANG ; RUEY-MEEI WU ; YONG-KWANG TU ; JUI-CHANG TASI ; HAM-MIN TSENG; SHENG-HONG TSENG ; ANN-LII CHENG ; CHING-HUNG LIN Lung Cancer2626
1082010The prevalence and assessment of ErbB2-positive breast cancer in Asia: A literature surveyTan Y.O; Han S; YEN-SHEN LU ; Yip C.-H; Sunpaweravong P; Jeong J; Caguioa P.B; Aggarwal S; Yeoh E.M; Moon H.Cancer1716
1092010Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatinYU-YUN SHAO ; KUAN-TING KUO ; Hu F.-C.; YEN-SHEN LU ; CHIUN-SHENG HUANG ; JAU-YU LIAU ; Lee W.-C.; CHIUN HSU ; WEN-HUNG KUO ; KING-JEN CHANG ; CHING-HUNG LIN ; ANN-LII CHENG Japanese Journal of Clinical Oncology2824
1102010Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinibVogel C; Chan A; Gril B; Kim S.-B; Kurebayashi J; Liu L; YEN-SHEN LU ; Moon H.Japanese Journal of Clinical Oncology2119
1112009Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in AsiaCHING-HUNG LIN ; JAU-YU LIAU ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Lee W.-C.; KUAN-TING KUO ; Ying-Chun Shen ; SUNG-HSIN KUO ; Lan C.; Liu J.M.; WEN-HUNG KUO ; KING-JEN CHANG ; ANN-LII CHENG Cancer Epidemiology Biomarkers and Prevention9995
1122009Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU ; Voravud N; Shao Z.-M; Pritchard K.I.The Lancet Oncology2524
1132009Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinomaDA-LIANG OU ; Ying-Chun Shen ; JA-DER LIANG ; Liou J.-Y.; SUNG-LIANG YU ; Fan H.-H.; Wang D.-S.; YEN-SHEN LU ; CHIUN HSU ; ANN-LII CHENG Clinical Cancer Research3234
1142009Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathwayChen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG Journal of Biological Chemistry8984
1152009Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!DWANG-YING CHANG ; CHING-HUNG LIN ; YEN-SHEN LU Journal of Clinical Oncology21
1162008Histone deacetylase inhibitors in cancer therapySargeant, Aaron M.; Kulp, Samuel K.; YEN-SHEN LU ; ANN-LII CHENG ; Chen, Ching ShihCancer Epigenetics0
1172008Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cellsChen K.-F.; Yeh P.-Y.; KUN-HUEI YEH ; YEN-SHEN LU ; SHANG-YI HUANG ; ANN-LII CHENG Cancer Research114105
1182008Differential expression of glucocorticoid receptor in carcinomas of the human digestive systemHUANG-CHUN LIEN ; YEN-SHEN LU ; CHIA-TUNG SHUN ; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG Histopathology1817
1192008The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancersCHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG Oncologist1918
1202008Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patientsSUNG-HSIN KUO ; HUANG-CHUN LIEN ; You S.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; Chen T.-Z.; CHIUN-SHENG HUANG Breast1212
1212008NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cellsGao M.; Yeh P.Y.; YEN-SHEN LU ; Chang W.C.; Kuo M.-L.; ANN-LII CHENG Biochemical and Biophysical Research Communications2319
1222008OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinomaGao M.; Yeh P.Y.; YEN-SHEN LU ; CHIH-HUNG HSU ; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG Cancer Research131123
1232008FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signalingHung J.-H.; YEN-SHEN LU ; Wang Y.-C.; Ma Y.-H.; Wang D.-S.; Kulp S.K.; Muthusamy N.; Byrd J.C.; ANN-LII CHENG ; Chen C.-S.Cancer Research9693
1242007Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYEN-SHEN LU ; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; ZHONG-ZHE LIN ; Chen T.-J.; ANN-LII CHENG ; Chen C.-S.Hepatology8383
1252007A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerCHIA-CHI LIN ; ANN-LII CHENG ; CHIH-HUNG HSU ; YEN-SHEN LU ; CHIUN HSU ; KUN-HUEI YEH ; Wu C.-Y.; CHIUN-SHENG HUANG ; CHIH-HSIN YANG Anticancer Research22
1262007Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylationChen C.-S; Wang Y.-C; Yang H.-C; Huang P.-H; Kulp S.K; Yang C.-C; YEN-SHEN LU ; Matsuyama S; Chen C.-Y; Chen C.-S.Cancer Research160153
1272007Pneumatosis coli after etoposide chemotherapy for breast cancerI-LUN SHIH ; YEN-SHEN LU ; HSIU-PO WANG ; KAO-LANG LIU Journal of Clinical Oncology1212
1282006Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivityYEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG Lung Cancer3534
1292006Differential expression of glucocorticoid receptor in human breast tissues and related neoplasmsHUANG-CHUN LIEN ; YEN-SHEN LU ; ANN-LII CHENG ; Chang W.-C.; YUNG-MING JENG ; Kuo Y.-H.; CHIUN-SHENG HUANG ; KING-JEN CHANG ; Yao Y.-T.Journal of Pathology4848
1302006Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancerCh'ang H.-J.; Wang C.-C.; ANN-LII CHENG ; CHIUN HSU ; YEN-SHEN LU ; MING-CHU CHANG ; Lin J.-T.; HSIU-PO WANG ; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.Journal of Gastroenterology and Hepatology (Australia)88
1312006Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHaYEN-SHEN LU ; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG Journal of Endocrinology2321
1322005Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.F.; Chao H.J.; Ta-Chen Huang ; Chung C.Y.; Chang C.S.; CHIH-HSIN YANG ; ANN-LII CHENG British Journal of Cancer77
1332005Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patientsSu W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG ; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU ; YEN-SHEN LU ; HWEI-FANG TIEN ; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN World Journal of Gastroenterology1814
1342005Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptorsYEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG World Journal of Gastroenterology2625
1352005Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancerKUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Lin J.-F.; CHIUN HSU ; SUNG-HSIN KUO ; Li Jr. S.; ANN-LII CHENG Oncology2222
1362004Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinomaYEN-SHEN LU ; Hsu C; Li C.-C; SUNG-HSIN KUO ; Yeh K.-H; Yang C.-H; Hsu C.-H; Wu C.-Y; Cheng A.-L.Hepato-Gastroenterology1413
1372004Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRIYEUN-CHUNG CHANG ; CHIUN-SHENG HUANG ; Liu Y.-J.; Chen J.-H.; YEN-SHEN LU ; WEN-YIH TSENG Physics in Medicine and Biology7063
1382004Recent advances in the management of primary breast cancersYEN-SHEN LU ; SUNG-HSIN KUO ; CHIUN-SHENG HUANG Journal of the Formosan Medical Association1514
1392004Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tractCHIUN HSU ; Ying-Chun Shen ; CHIH-HSIN YANG ; KUN-HUEI YEH ; YEN-SHEN LU ; CHIH-HUNG HSU ; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG British Journal of Cancer4240
1402003High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine LeiomyosarcomaKUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG Anticancer Research33
1412002Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cellsChuang S.-E.; Yeh P.-Y.; YEN-SHEN LU ; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG Biochemical Pharmacology161138
1422002A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracilCHIH-HUNG HSU ; ANN-LII CHENG ; CHIUN HSU ; CHIH-HSIN YANG ; YEN-SHEN LU ; CHIA-CHI LIN ; Bu C.-F.; KUN-HUEI YEH Anticancer Research1212
1432002Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinomaCHIUN HSU ; CHIUN-SHENG HUANG ; Chao T.-Y.; YEN-SHEN LU ; Bu C.-F.; Chen M.M.; KING-JEN CHANG ; ANN-LII CHENG Cancer1211
1441996Transient ‘Milky Urine’ after Cardiac Catheterization: Another Unreported Cause of Non-Parasitic ChyluriaChen H.-S.; Yen T.-S.; YEN-SHEN LU ; JYH-CHIN YANG ; Ko Y.-L.Nephron98